Trial NCT03227432

View at ClinicalTrials.gov 
Org. Study IDs: 16-645

Last trial update was posted on 2018-08-14

MeSH Interventions

Dexamethasone Elotuzumab Nivolumab Pomalidomide

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions


Stopping Reasons

Withdrawn before enrollment due to issues around the FDA hold on PD-1/PD-L1 drugs in combination with IMIDs.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID